Tag Archives: NASDAQAMRN

[ad_1] Amarin Corporation plc (NASDAQ: AMRN) shares were falling Monday following the presentation of detailed primary results from the the late-stage REDUCE-IT study that evaluated Vascepa, held at a late-breaking session at …

[ad_1] Introduction I hope that everyone reading this has a baseline knowledge of Amarin (AMRN), its sole product Vascepa, and the REDUCE-IT cardiovascular outcomes trial, or CVOT. Further, presumably everyone is aware …